Skip to main content
TipRanks
Go Ultimate75% OFF

Derace Schaffer Insider Profile

4 Followers

Derace Schaffer, Director at Lantheus, holds 25.09K shares in Lantheus (Ticker: LNTH), holds 601.85K shares in Altimmune (Ticker: ALT), holds 950.76K shares in American Caresource Holdings (Ticker: GNOW).

Derace Schaffer's Trading History

LNTH
Lantheus
Mar 05, 2020DirectorUninformative Buy―$2.55M
ALT
Altimmune
Jan 02, 2018DirectorInformative Buy186.83K$990.04K
GNOW
American Caresource Holdings
Jun 18, 2012―Informative Buy1.24K$9.51K

You May Also Like

Derace Schaffer insider profile FAQ

What is the percentage of profitable transactions made by Derace Schaffer?
The percentage of profitable transactions made by Derace Schaffer is 31%.
What is the average return per transaction made by Derace Schaffer?
The average return per transaction made by Derace Schaffer is -61.40%.
What stocks does Derace Schaffer hold?
Derace Schaffer holds: LNTH, ALT, GNOW stocks.
What was Derace Schaffer's most profitable transaction?
Derace Schaffer’s most profitable transaction was an Informative Sell of LNTH stock on May 16, 2017. The return on the trade was 11.50%.
What is Derace Schaffer's role in Lantheus?
Derace Schaffer's role in Lantheus is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.